Testosterone replacement therapy in blood donors modulates erythrocyte metabolism and susceptibility to hemolysis in cold storage. Issue 1 (18th October 2020)

• Record Type: Journal Article
• Authors: Alexander, Keisha; Hazegh, Kelsey; Fang, Fang; Sinchar, Derek; Kiss, Joseph E.; Page, Grier P.; DʼAlessandro, Angelo; Kanias, Tamir
• Is Part Of: Transfusion. Volume 61:Issue 1(2021)
• Page Start: 108
• Page End: 123
• Publication Date: 2020-10-18
• Subjects: Hematology -- Periodicals; Blood -- Transfusion -- Periodicals; Blood Group Antigens -- Periodicals; Blood Preservation -- Periodicals; Blood Transfusion -- Periodicals; 615
• DOI: 10.1111/trf.16141
• Languages: English
• ISSNs: 0041-1132

Abstract

Abstract: Background: Red blood cells (RBCs) derived from patients who receive testosterone replacement therapy (TRT) may be considered eligible for component production and transfusion. The aim of this study was to identify testosterone‐dependent changes in RBC metabolism and to evaluate its impact on susceptibility to hemolysis during cold storage. Study Design and Methods: We characterized stored RBCs from two cohorts of TRT patients who were matched with control donors (no TRT) based upon sex, age, and ethnicity. We further evaluated the impact of testosterone deficiency (orchiectomy) on RBC metabolism in FVB/NJ mice. RBC metabolites were quantified by ultra‐high‐pressure liquid chromatography‐mass spectrometry. RBC storage stability was determined in RBC units from TRT and controls by quantifying storage, osmotic, and oxidative hemolysis. Results: Orchiectomy in mice was associated with significant ( P < 0.05) changes in RBC metabolism as compared with intact males including increased levels of acyl‐carnitines, long‐chain fatty acids (eg, docosapentaenoic acids), arginine, and dopamine. Stored RBCs from TRT patients exhibited higher levels of pentose phosphate pathway metabolites, glutathione, and oxidized purines (eg, hypoxanthine), suggestive of increased activation of antioxidant pathways in this group. Further analyses indicated significant changes in free fatty acids and acyl‐carnitines in response to testosterone therapies. With regard to hemolysis, TRT was associated with enhanced susceptibility to osmotic hemolysis. Correlation analyses identified acyl‐carnitines as significant modifiers of RBC predisposition to osmotic and oxidative hemolysis. Conclusions: These observations provide new insights into testosterone‐mediated changes in RBC metabolome and biology that may impact the storage capacity and posttransfusion efficacy of RBCs from TRT donors.